Akili grabs $11.9 mln Series B
Akili Interactive Labs Inc, which is developing treatments and diagnostics for cognitive disorders, has raised an addition $11.9 million in its recent Series B financing, bringing the total tally to $42.4 million. The investors included M Ventures and Amgen Ventures.
20 July 2016•1 min read
